INFARMED Leadership Appointments: A New Era in ...

By João L. Carapinha

January 6, 2026

INFARMED Leadership Appointments: Renewed Expertise for Medicines Oversight The Portuguese Council of Ministers has issued
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Hea...
Positive ARTISTRY-2 Trial Results for BIC LEN HIV Regimen
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Arexvy RSV Vaccine Expansion: Broader Access and Impact on Adult Health Outcomes
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
AI Governance Pharmaceuticals: Ensuring Ethical AI Integration in the Medicin...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...